Tus kws kho mob
QP82-24 Enhanced Authorization Submissions through Availity Essentials
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3221 - 3230 ntawm 4303
Tus kws kho mob
QP80-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
bc-mhcp-pharmprogpolicynotifctn-effective-12-1-24.pdf
Kev Yuav Khoom thiab Kev Kawm Paub
2025 Spanish Individual & Family Decision Guide
Tus kws kho mob
2024 November Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P72-24 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P70-24 Continuous Glucose Monitor Billing for Medicare Products
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P66-24 2025 Renewal Changes Summary for Institutional Providers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P71-24 Change to Management of Specific Specialty Utilization Management (UM) Programs
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P67-24 2025 Renewal Changes Summary for Blue Plus Primary Care Clinic Providers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024